Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/27/2001 | US20010055596 Compositions and methods for therapy and diagnosis of colon cancer |
12/27/2001 | US20010055591 Antithrombin H-helix mutants |
12/27/2001 | US20010055586 Methods and means for targeted gene delivery |
12/27/2001 | US20010055585 Frnk proteins in the treatment of tumor cells |
12/27/2001 | US20010055583 Methods of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby |
12/27/2001 | US20010055582 Erythropoietin solution preparation |
12/27/2001 | CA2805216A1 Antigenic polypeptides from staphylococcus |
12/27/2001 | CA2414228A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof |
12/27/2001 | CA2414065A1 Cgi-69 compositions and methods of use |
12/27/2001 | CA2414046A1 Conserved diaphanous-related formin autoregulatory domain (dad) |
12/27/2001 | CA2414033A1 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
12/27/2001 | CA2414028A1 Low oxygen affinity mutant hemoglobins |
12/27/2001 | CA2414020A1 Methods and compositions for the treatment of peripheral artery disease |
12/27/2001 | CA2414015A1 Human receptors |
12/27/2001 | CA2414010A1 Secreted redox proteins |
12/27/2001 | CA2414005A1 Novel compounds |
12/27/2001 | CA2413986A1 Gp354 nucleic acids and polypeptides |
12/27/2001 | CA2413959A1 Fusion proteins of mycobacterium tuberculosis |
12/27/2001 | CA2413860A1 Regulation of cellproliferation and differentiation using topically applied peptides |
12/27/2001 | CA2413830A1 Peptide and polypeptide inhibitors of complement c1s |
12/27/2001 | CA2413754A1 Canine hepatocyte growth factor |
12/27/2001 | CA2413556A1 Positively-charged peptide nucleic acid analogs with improved properties |
12/27/2001 | CA2413548A1 Root-specific promoter from arabidopsis |
12/27/2001 | CA2413468A1 Methods and means for regulation of gene expression |
12/27/2001 | CA2413454A1 A g-protein coupled receptor |
12/27/2001 | CA2413452A1 Clk-2, cex-7 and coq-4 genes, and uses thereof |
12/27/2001 | CA2413450A1 Streptococcus antigens |
12/27/2001 | CA2413435A1 A recombinant cell line expressing gpcrx11 as a functional receptor validated by angiopeptin and useful for screening of agonists and antagonists |
12/27/2001 | CA2412942A1 Nucleic acid sequences and methods for the modification of plant gene expression |
12/27/2001 | CA2412901A1 Bispecific fusion protein and method of use for enhancing effector cell killing of target cells |
12/27/2001 | CA2412849A1 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
12/27/2001 | CA2412734A1 Renal regulatory elements and methods of use thereof |
12/27/2001 | CA2412484A1 G-protein coupled receptors |
12/27/2001 | CA2412219A1 Transgenically produced platelet derived growth factor |
12/27/2001 | CA2412215A1 Angiogenesis-modulating compositions and uses |
12/27/2001 | CA2412110A1 Osteolevin gene polymorphisms |
12/27/2001 | CA2411978A1 Transgenic mice containing targeted gene disruptions |
12/27/2001 | CA2411945A1 Chimeric human papillomavirus (hpv) l1 molecules and uses therefor |
12/27/2001 | CA2411896A1 Hypersensitive response eliciting domains of bacterial harpins and use thereof |
12/27/2001 | CA2411857A1 Peptides, compositions and methods for the treatment of burkholderia cepacia |
12/27/2001 | CA2411756A1 Mutation associated with epilepsy |
12/27/2001 | CA2410864A1 Compositions comprising net-4 modulations and their use for treating neoplastic disease |
12/27/2001 | CA2410224A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
12/27/2001 | CA2409778A1 Secreted proteins |
12/27/2001 | CA2409776A1 G-protein coupled receptors |
12/27/2001 | CA2408630A1 Novel enterokinase cleavage sequences |
12/27/2001 | CA2407788A1 Method for activating peroxisome proliferator activated receptor-.gamma. |
12/26/2001 | CN1328570A Antagonistic analogs in GH-RH inhibiting IGF-I and -II |
12/26/2001 | CN1328569A TGF (b) 1 inhibitor peptides |
12/26/2001 | CN1328568A Peptide derivative |
12/26/2001 | CN1328567A Mammaglobin, a secreted mammary-specific breast cancer protein |
12/26/2001 | CN1328470A Chemokine receptor peptide vaccines for treatment and prevention of diabetes |
12/26/2001 | CN1328061A Application of genetically engineered fish growth hormone in aquatic product culture |
12/26/2001 | CN1328060A Polypeptide-human oxysteroid bindin 38.72 and polynucleotide for coding it |
12/26/2001 | CN1328059A Polypeptide-human cell cyclin G29.13 and polynucleotide for coding it |
12/26/2001 | CN1328058A Polypeptide-human Maxi Potassiumion channel beta2 subunit 11.55 and polynucleotide for coding it |
12/26/2001 | CN1328056A Polypeptide-human zinc finger protein 10.56 and polynucleotide for coding it |
12/26/2001 | CN1328055A Polypeptide-insulin-like growth factor bindin 16.17 and polynucleotide for coding it |
12/26/2001 | CN1328054A Polypeptide-human Homer associated protein 12.54 and polynucleotide for coding it |
12/26/2001 | CN1328053A Polypeptide-human ftsH protein 16.83 and polynucleotide for coding it |
12/26/2001 | CN1328052A Polypeptide-human myoglobulin 25.19 and polynucleotide for coding it |
12/26/2001 | CN1328051A Polypeptide-human INFR/NGFR protein 14 containing cytochrome C structure domain and polynucleotide for coding it |
12/26/2001 | CN1328050A Polypeptide-human natriuretic peptide receptor 9 and polynucleotide for coding it |
12/26/2001 | CN1328049A Polypeptide-insulin-like growth factor bindin 11.88 and polynucleotide for coding it |
12/26/2001 | CN1328048A Polypeptide-human I-type transcription growth factor beta receptor associated protein 9.57 and polynucleotide for coding it |
12/26/2001 | CN1328047A Polypeptide-human Karyopherin 3 protein 56.1 and polynucleotide for coding it |
12/26/2001 | CN1328046A Polypeptide-human zinc finger protein 24.97 and polynucleotide for coding it |
12/26/2001 | CN1328045A Polypeptide-human BAF 57 protein 11.55 and polynucleotide for coding it |
12/26/2001 | CN1328044A Polypeptide-human shear factor 22.55 and polynucleotide for coding it |
12/26/2001 | CN1328043A Polypeptide-human periplastic dynein intermediate chain (IC) 9.35 and polynucleotide for coding it |
12/26/2001 | CN1328042A Polypeptide-human Parkinson syndrome associated protein 13.31 and polynucleotide for coding it |
12/26/2001 | CN1328041A Polypeptide-human Parkinson syndrome associated protein 13.2 and polynucleotide for coding it |
12/26/2001 | CN1328040A Polypeptide-human zinc finger protein 18.04 and polynucleotide for coding it |
12/26/2001 | CN1328039A Polypeptide-human ribosomal protein L7all.77 and polynucleotide for coding it |
12/26/2001 | CN1328038A Polypeptide-human actin associated protein 13E-32 and polynucleotide for coding it |
12/26/2001 | CN1328037A Polypeptide-human mitochondrion ATP enzyme coupling factor F624.09 and polynucleotide for coding it |
12/26/2001 | CN1328036A Polypeptide-human p300/CBP binding factor 10.56 and polynucleotide for coding it |
12/26/2001 | CN1328035A Polypeptide-corticotrophin releasing factor 10 and polynucleotide for coding it |
12/26/2001 | CN1328034A Polypeptide-human zinc finger protein SAG protein 20.46 and polynucleotide for coding it |
12/26/2001 | CN1328033A Polypeptide-human Fe-S protein 9.46 and polynucleotide for coding it |
12/26/2001 | CN1328032A Polypeptide-human mitochondrion translation initiation factor 8.8 and polynucleotide for coding it |
12/26/2001 | CN1328031A Polypeptide-human cobalamin bindin 10.45 and polynucleotide for coding it |
12/26/2001 | CN1328030A Polypeptide-human cancer suppressor gene 98 and polynucleotide for coding it |
12/26/2001 | CN1328029A Polypeptide-human tre oncogene protein 10.56 and polynucleotide for coding it |
12/26/2001 | CN1328028A Polypeptide-human inhibitory glycine receptor-postsynaptic nexin 15.4 and polynucleotide for coding it |
12/26/2001 | CN1328027A Polypeptide-human CAD protein 9.02 and polynucleotide for coding it |
12/26/2001 | CN1328026A Polypeptide-human genetical multi-effect regulator 1(PLRG1) protein 9.9 and polynucleotide for coding it |
12/26/2001 | CN1328025A Polypeptide-human replication start codon initiation recognition complex subunit Orc4Lp(HsORC4L) 12.21 and polynucleotide for coding it |
12/26/2001 | CN1328024A Polypeptide-human Na-K pump 14.85 and polynucleotide for coding it |
12/26/2001 | CN1328023A Polypeptide-human rap 55 mRNA bindin 19 and polynucleotide for coding it |
12/26/2001 | CN1328022A Polypeptide-human zinc finger protein 10.89 and polynucleotide for coding it |
12/26/2001 | CN1328021A Polypeptide-human wither inhibitor 38.06 and polynucleotide for coding it |
12/26/2001 | CN1328020A Polypeptide-human zinc finger protein 17.93 and polynucleotide for coding it |
12/26/2001 | CN1328019A Polypeptide-estrogen receptor associated protein 24.31 and polynucleotide for coding it |
12/26/2001 | CN1328018A Polypeptide-human TNFR/NGFR protein 10 containing cytochrome C structure domain and polynucleotide for coding it |
12/26/2001 | CN1328017A Polypeptide-human TNFR/NGFR protein 12 containing cytochrome C structure domain and polynucleotide for coding it |
12/26/2001 | CN1328016A Polypeptide-human glutamate receptor active protein 11.55 and polynucleotide for coding it |
12/26/2001 | CN1328015A Polypeptide-human cell wither associated protein 14.52 and polynucleotide for coding it |
12/26/2001 | CN1328014A Polypeptide-TGF beta receptor associated protein 110.23 and polynucleotide for coding it |
12/26/2001 | CN1328013A Polypeptide-laminin B210.67 and polynucleotide for coding it |